|Print Page | Close Window|
|May 17, 2013 - 4:05 p.m.|
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
|May 15, 2013 - 6:31 p.m.|
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
|May 14, 2013 - 4:06 p.m.|
Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.